What are the research interests of Hallvard Holdaas, MD, PhD?
Hallvard Holdaas, MD, PhD, is senior consultant in Nephrology at Department of Transplant Medicine, Oslo University Hospital, Rikshospitalet, Norway. His primary research interests are immunosuppression, dyslipidemia, and CVD in renal transplant recipients. He was the PI in the ALERT trial (fluvastatin) and co-PI in the AURORA and SHARP trials.